Phibro Animal Health Corp. (NASDAQ:PAHC) was upgraded by TheStreet from a “hold” rating to a “buy” rating in a research report issued on Friday.
A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group AG reiterated a “buy” rating and issued a $29.00 target price on shares of Phibro Animal Health Corp. in a research note on Tuesday, August 30th. Guggenheim set a $30.00 price target on shares of Phibro Animal Health Corp. and gave the company a “buy” rating in a research report on Monday, September 12th. Zacks Investment Research lowered shares of Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday, August 23rd. Finally, Morgan Stanley set a $23.00 price target on shares of Phibro Animal Health Corp. and gave the company a “sell” rating in a research report on Sunday, September 4th. Three research analysts have rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. Phibro Animal Health Corp. has an average rating of “Hold” and a consensus price target of $30.67.
Shares of Phibro Animal Health Corp. (NASDAQ:PAHC) opened at 27.23 on Friday. The firm has a market cap of $1.07 billion, a price-to-earnings ratio of 13.15 and a beta of 1.34. Phibro Animal Health Corp. has a 12 month low of $16.80 and a 12 month high of $35.69. The firm has a 50-day moving average of $24.59 and a 200-day moving average of $22.05.
Phibro Animal Health Corp. (NASDAQ:PAHC) last released its earnings results on Monday, August 29th. The company reported $0.40 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.02. The firm had revenue of $189.20 million for the quarter. Phibro Animal Health Corp. had a net margin of 11.02% and a return on equity of 105.21%. The firm’s revenue was up 2.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.44 earnings per share. On average, analysts anticipate that Phibro Animal Health Corp. will post $1.41 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, September 28th. Investors of record on Wednesday, September 7th were issued a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend was Friday, September 2nd. Phibro Animal Health Corp.’s dividend payout ratio (DPR) is presently 19.42%.
Hedge funds have recently bought and sold shares of the company. BNP Paribas Arbitrage SA raised its stake in Phibro Animal Health Corp. by 102.6% in the second quarter. BNP Paribas Arbitrage SA now owns 6,150 shares of the company’s stock worth $115,000 after buying an additional 3,114 shares during the period. Nuveen Fund Advisors LLC purchased a new stake in Phibro Animal Health Corp. during the second quarter worth $196,000. Nationwide Fund Advisors raised its stake in Phibro Animal Health Corp. by 5.6% in the second quarter. Nationwide Fund Advisors now owns 11,921 shares of the company’s stock worth $222,000 after buying an additional 637 shares during the period. Highbridge Capital Management LLC purchased a new stake in Phibro Animal Health Corp. during the second quarter worth $232,000. Finally, Arizona State Retirement System raised its stake in Phibro Animal Health Corp. by 3.3% in the first quarter. Arizona State Retirement System now owns 9,400 shares of the company’s stock worth $254,000 after buying an additional 300 shares during the period. 47.88% of the stock is currently owned by institutional investors and hedge funds.
Phibro Animal Health Corp. Company Profile
Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.
Receive News & Ratings for Phibro Animal Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp. and related companies with MarketBeat.com's FREE daily email newsletter.